Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]Acetate PET in LAM Patients
NCT05467397Phase 2Active, not recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2021
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Brigham and Women's Hospital. Primary endpoint: Quantitative Analysis of [11C]Acetate Uptake in LAM Lesions. Started Aug 2021; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05467397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05467397.